Spots Global Cancer Trial Database for A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer
Official Title: A Phase 2, Randomized, Open-label, Platform Study Utilizing a Master Protocol to Evaluate Novel Immunotherapy Combinations in Participants With Previously Untreated, Locally Advanced/Metastatic, Programmed Death Ligand 1-Selected Non-Small-Cell Lung Cancer
Study ID: NCT05565378
Conditions
Study Description
Brief Summary: This study will evaluate the efficacy, safety, pharmacokinetics (PK), and pharmacodynamics (PDy) of novel immunotherapy combinations compared with immunotherapy monotherapy in participants with Programmed death ligand-1 (PD L-1) high (Tumor cells \[TC\]/ Tumor proportion score \[TPS\] ≥ 50%), previously untreated, unresectable, locally advanced or metastatic NSCLC. Drug name mentioned as Belrestotug, GSK4428859A, and EOS884448 are all interchangeable for the same compound. In the rest of the document, the drug will be referred to as Belrestotug.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
GSK Investigational Site, Los Angeles, California, United States
GSK Investigational Site, Plantation, Florida, United States
GSK Investigational Site, Baltimore, Maryland, United States
GSK Investigational Site, Boston, Massachusetts, United States
GSK Investigational Site, Albuquerque, New Mexico, United States
GSK Investigational Site, Bryn Mawr, Pennsylvania, United States
GSK Investigational Site, Media, Pennsylvania, United States
GSK Investigational Site, Paoli, Pennsylvania, United States
GSK Investigational Site, Wynnewood, Pennsylvania, United States
GSK Investigational Site, Chattanooga, Tennessee, United States
GSK Investigational Site, Morgantown, West Virginia, United States
GSK Investigational Site, Ciudad Autonoma Buenos Aires, Buenos Aires, Argentina
GSK Investigational Site, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
GSK Investigational Site, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
GSK Investigational Site, Florida, Buenos Aires, Argentina
GSK Investigational Site, Mar del Plata, Buenos Aires, Argentina
GSK Investigational Site, Cipoletti, Rio Negro, Río Negro, Argentina
GSK Investigational Site, Buenos Aires, , Argentina
GSK Investigational Site, Ciudad Autonoma de Buenos Aires, , Argentina
GSK Investigational Site, San Juan, , Argentina
GSK Investigational Site, Santa Fe, , Argentina
GSK Investigational Site, Edegem, , Belgium
GSK Investigational Site, Vitória, Espírito Santo, Brazil
GSK Investigational Site, Porto Alegre, Rio Grande Do Sul, Brazil
GSK Investigational Site, Barretos, São Paulo, Brazil
GSK Investigational Site, Bela Vista, São Paulo, Brazil
GSK Investigational Site, São Paulo, , Brazil
GSK Investigational Site, Oulu, , Finland
GSK Investigational Site, Tampere, , Finland
GSK Investigational Site, Turku, , Finland
GSK Investigational Site, Vaasa, , Finland
GSK Investigational Site, Bordeaux Cedex, , France
GSK Investigational Site, Caen Cedex 9, , France
GSK Investigational Site, Marseille, , France
GSK Investigational Site, Quimper cedex, , France
GSK Investigational Site, Strasbourg Cedex, , France
GSK Investigational Site, Heidelberg, Baden-Wuerttemberg, Germany
GSK Investigational Site, Essen, Nordrhein-Westfalen, Germany
GSK Investigational Site, Dresden, Sachsen, Germany
GSK Investigational Site, Grosshansdorf, Schleswig-Holstein, Germany
GSK Investigational Site, Jena, Thueringen, Germany
GSK Investigational Site, Berlin, , Germany
GSK Investigational Site, Athens, , Greece
GSK Investigational Site, Athens, , Greece
GSK Investigational Site, Athens, , Greece
GSK Investigational Site, Larisa, , Greece
GSK Investigational Site, Thessaloniki, , Greece
GSK Investigational Site, Thessaloniki, , Greece
GSK Investigational Site, Thessaloniki, , Greece
GSK Investigational Site, Thessaloniki, , Greece
GSK Investigational Site, Budapest, , Hungary
GSK Investigational Site, Farkasgyepű, , Hungary
GSK Investigational Site, Gyöngyös, , Hungary
GSK Investigational Site, Tatabánya, , Hungary
GSK Investigational Site, Törökbálint, , Hungary
GSK Investigational Site, Avellino, Campania, Italy
GSK Investigational Site, Roma, Lazio, Italy
GSK Investigational Site, Genova, Liguria, Italy
GSK Investigational Site, Firenze, Toscana, Italy
GSK Investigational Site, Livorno, Toscana, Italy
GSK Investigational Site, Legnago (VR), Veneto, Italy
GSK Investigational Site, Bergamo, , Italy
GSK Investigational Site, Chiba, , Japan
GSK Investigational Site, Fukuoka, , Japan
GSK Investigational Site, Hyogo, , Japan
GSK Investigational Site, Kanagawa, , Japan
GSK Investigational Site, Osaka, , Japan
GSK Investigational Site, Saitama, , Japan
GSK Investigational Site, Incheon, , Korea, Republic of
GSK Investigational Site, Seoul, , Korea, Republic of
GSK Investigational Site, Seoul, , Korea, Republic of
GSK Investigational Site, Seoul, , Korea, Republic of
GSK Investigational Site, Suwon, Gyeonggi-do, , Korea, Republic of
GSK Investigational Site, Toluca de Lerdo, Estado De México, Mexico
GSK Investigational Site, Guadalajara, Jalisco, Mexico
GSK Investigational Site, San Luis Potosí, , Mexico
GSK Investigational Site, Enschede, , Netherlands
GSK Investigational Site, Groningen, , Netherlands
GSK Investigational Site, Leeuwarden, , Netherlands
GSK Investigational Site, Utrecht, , Netherlands
GSK Investigational Site, Lublin, , Poland
GSK Investigational Site, Olsztyn, , Poland
GSK Investigational Site, Prabuty, , Poland
GSK Investigational Site, Siedlce, , Poland
GSK Investigational Site, Wroclaw, , Poland
GSK Investigational Site, Guimarães, , Portugal
GSK Investigational Site, Lisboa, , Portugal
GSK Investigational Site, Lisboa, , Portugal
GSK Investigational Site, Porto, , Portugal
GSK Investigational Site, Vila Nova de Gaia, , Portugal
GSK Investigational Site, Parktown, Gauteng, South Africa
GSK Investigational Site, Kraaifontein, Western Province, South Africa
GSK Investigational Site, Pretoria, , South Africa
GSK Investigational Site, Badajoz, , Spain
GSK Investigational Site, Badalona, , Spain
GSK Investigational Site, Barcelona, , Spain
GSK Investigational Site, L'Hospitalet de Llobregat, , Spain
GSK Investigational Site, Las Palmas De Gran Canaria, , Spain
GSK Investigational Site, Madrid, , Spain
GSK Investigational Site, Madrid, , Spain
GSK Investigational Site, Madrid, , Spain
GSK Investigational Site, Malaga, , Spain
GSK Investigational Site, Pozuelo De Alarcón. Madrid., , Spain
GSK Investigational Site, Valencia, , Spain
GSK Investigational Site, Valencia, , Spain
GSK Investigational Site, Bangkok, , Thailand
GSK Investigational Site, Chiangmai, , Thailand
GSK Investigational Site, Khlong Luang, , Thailand
GSK Investigational Site, Khon Kaen, , Thailand
GSK Investigational Site, Songkla, , Thailand
GSK Investigational Site, Ankara, , Turkey
GSK Investigational Site, Ankara, , Turkey
GSK Investigational Site, Antalya, , Turkey
GSK Investigational Site, Istanbul, , Turkey
GSK Investigational Site, Abu Dhabi, , United Arab Emirates
GSK Investigational Site, Abu-Dhabi, , United Arab Emirates
GSK Investigational Site, Al-Ain, , United Arab Emirates
GSK Investigational Site, Dubai, , United Arab Emirates
GSK Investigational Site, Northwood, Middlesex, United Kingdom
GSK Investigational Site, Wolverhampton, West Midlands, United Kingdom
GSK Investigational Site, Middlesbrough, , United Kingdom
Contact Details
Name: GSK Clinical Trials
Affiliation: GlaxoSmithKline
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
